MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 2,625.00
+10.00 (0.38%)
Jul 21, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 89.63 billion as of July 21, 2026. Its market cap has decreased by -39.40% in one year.
Market Cap
89.63B
Enterprise Value
53.46B
Revenue
4.79B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,625.00
ChartMarket Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 89.63B, a decrease of -75.27%. That is a compound annual growth rate of -19.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 89.63B | -60.85% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helixmith | 151.72B |
| NeoImmuneTech | 128.53B |
| Macrogen | 119.58B |
| Genexine | 104.15B |
| Vaxcell-Bio Therapeutics | 92.22B |
| Amicogen | 80.18B |
| iNtRON Biotechnology | 76.51B |
| ENCell | 66.95B |